Vladimir Janković

420 citations
11 papers · 329 indexed · h-index 6
Topics
Bioactive Compounds and Antitumor Agents (2 papers)Acute Myeloid Leukemia Research (1 paper)Diabetic Foot Ulcer Assessment and Management (1 paper)

In The Last Decade

Vladimir Janković

9 papers receiving 323 citations

Peers

Vladimir Janković
Comparison fields: 5 of 55
  • Molecular Biology 206
  • Hematology 86
  • Oncology 53
  • Immunology 49
  • Genetics 45
Replace Vladimir Janković with:
Vladimir Janković United States
Priti Anand United States
Reza Nejati United States
Rositsa Koleva United States
Patricia S. Hähnel Germany
Sonja Röhrs Germany
Junko Zenkoh Japan
Mingchao Ma United States
Brian A. Wadugu United States
Muamera Zulcic United States
Vladimir Janković relative to Vladimir Janković United States Vladimir Janković's profile →
Citations per field
00.5×3.3×
Vladimir Janković · 1×
Citations per year

Countries citing papers authored by Vladimir Janković

Since Specialization
Citations

This map shows the geographic impact of Vladimir Janković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Janković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Janković more than expected).

Fields of papers citing papers by Vladimir Janković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Janković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Janković. The network helps show where Vladimir Janković may publish in the future.

Co-authorship network of co-authors of Vladimir Janković

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Janković. A scholar is included among the top collaborators of Vladimir Janković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Janković. Vladimir Janković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 2
5 26
6 29
7 146
8 2
9 57
10 38
11 28

About Vladimir Janković

Vladimir Janković is a scholar working on Toxicology, Hematology and Urology, having authored 11 papers that have together received 329 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (2 papers), Acute Myeloid Leukemia Research (1 paper) and Diabetic Foot Ulcer Assessment and Management (1 paper). The work is most often cited by research in Hematology (86 citations), Genetics (45 citations) and Molecular Biology (206 citations). Vladimir Janković has collaborated with scholars based in Serbia, United States and Canada. Frequent co-authors include Vladimir Trajković, Tatjana Samardžić, Richard F. Dunne, Hediye Erdjument‐Bromage, Paul Tempst, Jin Zhang, Andrew Xiao, Sílvia Menéndez, C. David Allis and Gang Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026